A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes
Launched by BOSTON CHILDREN'S HOSPITAL · Sep 3, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Epilepsy-Dyskinesia Study is a research project that aims to better understand specific genetic conditions that cause both epilepsy (seizures) and movement disorders in children. These conditions, known as epilepsy-dyskinesia syndromes, are rare and can vary widely in their symptoms and how they affect individuals. The study will collect information through surveys from multiple centers around the world, focusing on details like when symptoms began, how they progress, and any related health issues. By analyzing this data, researchers hope to uncover patterns that link genetic variations to the symptoms experienced by patients, which could lead to more personalized treatments in the future.
To participate in this study, children aged 0 to 18 who have a movement disorder and a specific genetic mutation related to epilepsy-dyskinesia syndromes may be eligible. If your child qualifies, they will be asked to provide information about their medical history through a survey. This study is important because it seeks to bring together data from many different countries, helping to create a clearer picture of these complex conditions and improve care for affected children.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Children between 0 - 18 years of age with a movement disorder and a pathogenic or likely pathogenic variant in one of the genes of interest:
- • AARS2 ALG13 AP3B2 AP4B1 AP4E1 AP4M1 AP4S1 ARX ATP1A3 CACNA1A CACNA1E CACNA2D2 CDKL5 CSTB DARS2 DLAT DLD DNM1 EARS2 EPG5 FARS2 FOXG1 FRRS1L GABRA1 GABRA2 GABRB2 GABRB3 GABRG2 GRIA2 GRIA4 GRIN1 GRIN2A GRIN2B GRIN2D GNAO1 HARS2 HNRNPU IQSEC2 KCNA2 KCNB1 KCNC1 KCNMA1 KCNQ2 KCNQ3 KCNT1 LARS2 MECP2 MEF2C MTND5 MTTL1 MTTK NARS2 NHLRC1 PDE10A PDE2 PCDH12 PCDH19 PDK3 PIGP PIGQ PIGS PIGN POLG PDHA1 PDHB PDHX PRRT2 PURA RHOBTB2 SCN1A SCN1B SCN2A SCN8A SCN9A SLC13A5 SLC1A2 SLC2A1 SLC25A22 SMCA1 SNP14 ST3GAL3 STXBP1 SPTAN1 SYNGAP1 TBC1D24 TBL1WL1 TARS2 UBA5 UBE3A VAMP2 VARS2 WARS2 WDOX WDR45 YIF1B YWHAG
- Exclusion Criteria:
- • Not having such diagnosis and/or not presenting a movement disorder.
About Boston Children's Hospital
Boston Children's Hospital is a leading pediatric healthcare institution renowned for its commitment to advancing child health through innovative research and exceptional clinical care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise in pediatric medicine to conduct rigorous and ethically sound research studies aimed at improving treatment options and outcomes for children. With a collaborative approach that integrates cutting-edge technology and multidisciplinary teams, Boston Children's Hospital is dedicated to translating scientific discoveries into practical applications that enhance the well-being of young patients and their families.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported